Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 22Recruiting 15Not yet recruiting 3Completed 3

Sponsor Class

OTHER 2NETWORK 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1CNS 1

Conditions

Wilms Tumor 1Neoplasms 1Glioma 1

Interventions

pembrolizumab 17Carboplatin 13Paclitaxel 12Cisplatin 12Radiation 10Doxorubicin 10Cyclophosphamide 9Radiotherapy 8Vincristine 7Nivolumab 7Metformin 7Etoposide 7Cytarabine 7Radiotherapy, Intensity-Modulated 6Magnetic Resonance Spectroscopy 6Leucovorin 6Injections 6Fluorouracil 6tislelizumab 5Prednisone 5Pemetrexed 5Methotrexate 5Ipilimumab 5Cetuximab 5Bevacizumab 5fludarabine 4durvalumab 4atezolizumab 4Specimen Handling 4Radiotherapy, Conformal 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × X-Rays × 30 days × Clear all
NCT05937776 2026-06-05

Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

OHSU Knight Cancer Institute

Completed
4 enrolled
CNS

Glioma

NCT00352534 2026-06-03

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor

Children's Oncology Group

Phase 3 Completed
808 enrolled 11 charts
Genitourinary

Wilms Tumor

NCT04014231 2026-06-01

Novel Single Wave Assessment in Measuring Cardiac Dysfunction and Metabolic Syndrome in Patients With Cancer

City of Hope Medical Center

Completed
159 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡